Galderma to Establish U.S. Headquarters in Miami’s Brickell District

In a major boost to South Florida’s growing reputation as a life sciences and healthcare hub, Switzerland-based Galderma has announced plans to establish its U.S. headquarters in Miami’s Brickell neighborhood. The global dermatology-focused pharmaceutical company revealed that it will base approximately 150 employees—many in key U.S. leadership positions—at the new office by 2028.

The decision underscores Miami’s emergence as a strategic location for global healthcare and aesthetics companies. The U.S. remains Galderma’s largest market, and the Miami metro area is known to have one of the country’s highest concentrations of dermatological aesthetic clinics and medical spas.

“Miami’s creativity, energy and forward-thinking spirit are consistent with Galderma’s ambitions,” said Flemming Ørnskov, CEO of Galderma. “The city’s emergence as a premium destination and a trend-setter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our U.S. headquarters. Being in Miami will enrich our business with top talent that will prove invaluable to our future success.”

Galderma’s move adds to the momentum transforming Brickell into a magnet for global corporate headquarters. With a lifestyle that blends business, innovation, and wellness, Miami continues to attract major players from across the financial, tech, and healthcare sectors.